IRIDEX Corp. (IRIX)
0.6892
+0.01
(+1.00%)
USD |
NASDAQ |
Sep 09, 14:06
IRIDEX Enterprise Value : 17.24M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 17.24M |
| September 04, 2026 | 17.55M |
| September 03, 2026 | 17.56M |
| September 02, 2026 | 17.92M |
| September 01, 2026 | 18.07M |
| August 31, 2026 | 17.96M |
| August 28, 2026 | 17.66M |
| August 27, 2026 | 17.76M |
| August 26, 2026 | 17.68M |
| August 25, 2026 | 17.83M |
| August 24, 2026 | 18.36M |
| August 21, 2026 | 18.53M |
| August 20, 2026 | 18.62M |
| August 19, 2026 | 19.00M |
| August 18, 2026 | 21.57M |
| August 17, 2026 | 20.69M |
| August 14, 2026 | 20.27M |
| August 13, 2026 | 19.72M |
| August 12, 2026 | 20.47M |
| August 11, 2026 | 20.86M |
| August 10, 2026 | 20.03M |
| August 07, 2026 | 19.83M |
| August 06, 2026 | 19.99M |
| August 05, 2026 | 20.06M |
| August 04, 2026 | 19.65M |
| Date | Value |
|---|---|
| August 03, 2026 | 19.73M |
| July 31, 2026 | 19.64M |
| July 30, 2026 | 19.85M |
| July 29, 2026 | 20.41M |
| July 28, 2026 | 20.71M |
| July 27, 2026 | 20.85M |
| July 24, 2026 | 20.88M |
| July 23, 2026 | 21.42M |
| July 22, 2026 | 21.30M |
| July 21, 2026 | 21.30M |
| July 20, 2026 | 21.49M |
| July 17, 2026 | 21.64M |
| July 16, 2026 | 21.93M |
| July 15, 2026 | 23.66M |
| July 14, 2026 | 24.01M |
| July 13, 2026 | 24.01M |
| July 10, 2026 | 24.53M |
| July 09, 2026 | 24.88M |
| July 08, 2026 | 24.88M |
| July 07, 2026 | 24.88M |
| July 06, 2026 | 24.88M |
| July 02, 2026 | 25.05M |
| July 01, 2026 | 25.75M |
| June 30, 2026 | 25.32M |
| June 29, 2026 | 25.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 210.25B |
| Align Technology, Inc. | 9.954B |
| AngioDynamics, Inc. | 591.77M |
| Accuray, Inc. | 177.77M |
| Alphatec Holdings, Inc. | 1.912B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.266M |
| Revenue (Quarterly) | 12.57M |
| Total Expenses (Quarterly) | 13.83M |
| EPS Diluted (Quarterly) | -0.0727 |
| Gross Profit Margin (Quarterly) | 33.56% |
| Profit Margin (Quarterly) | -10.07% |
| Earnings Yield | -29.92% |
| Normalized Earnings Yield | -29.90 |